Zobrazeno 1 - 10
of 2 157
pro vyhledávání: '"59"'
Autor:
Shuangwei Ying, He Huang, Wanzhuo Xie, Xiujin Ye, Jie Sun, Zhen Cai, Juan Hu, Jingsong He, Guoqing Wei, Jie Zhang, Yi Luo, Weiyan Zheng
Publikováno v:
Blood. 124:5273-5273
Objective: Between October 2010 to May 2014, 59 patients who diagnosed as FLT3-ITD positive aAML were analyzed. All the patients were signed informed consents to agree to provide their clinical information to this study. Informed consents were approv
Autor:
Elizabeth Macintyre, Béatrice Pedron, Olivier Casasnovas, Françoise Valensi, Najiba Boudjerra, Virginie Eclache, Odile Fenneteau, Nicole Dastugue, Sylvie Daliphard, Claude Preudhomme, Pascale Cornillet, Jean Luc Laï, Richard Garand, Hélène Jouault, Georges Flandrin, Frederic Davi, Pierre Fenaux, Christine Arnoulet, Pascale Lepelley, Francine Mugneret, Eliane Duchayne, Isabelle Radford, M Imbert, M J Mozziconacci, Roland Berger, Chrystele Bilhou-Naberra, Christophe Roumier, Marc Maynadié, Francine Garnache, Pascaline Talmant
Publikováno v:
Blood. 101(4)
Mutations of the AML1 gene are frequent molecular abnormalities in minimally differentiated acute myeloblastic leukemia (M0 AML), a rare type of AML. In this retrospective multicenter study, morphologic, immunophenotypical, cytogenetic, and molecular
Autor:
Ezio Nigra, Jean Gabarre, Emanuela Vaccher, Andrea Antinori, Giampiero di Gennaro, Renato Talamini, Marco Fasan, Adriana Ammassari, Maurizio Mena, Giuseppe Rossi, Michele Spina, Umberto Tirelli, Clara Schiantarelli
Publikováno v:
Blood. 100(6)
A phase 2 prospective study was performed to evaluate the feasibility and activity of a short, dose-intensive chemotherapy regimen and radiotherapy (the Stanford V regimen) plus highly active antiretroviral therapy (HAART) and granulocyte colony-stim
Autor:
Eduardo M. Sotomayor, Michael B Tomblyn, Bijal D. Shah, Jennifer L. Cultrera, Lubomir Sokol, Michael Jaglal, Celeste M. Bello
Publikováno v:
Blood. 120:4858-4858
Abstract 4858 Background Primary central nervous system lymphoma (PCNSL) is a rare aggressive variant of diffuse large B cell lymphoma (DLBCL) with a poor prognosis. Optimal therapeutic strategies have not been defined yet in primary CNS lymphoma. Hi
Autor:
Chunxia Dong, Li Zhang, Zhuanzhen Zheng, Li-Hong Hou, Yalin Wang, Yujin Lu, Zhenhua Qiao, Wenliang Chen, Bo Jiang, Rong Gong, Yanping Ma, Lianrong Xu, Guoxia Li
Publikováno v:
Blood. 118:4923-4923
Abstract 4923 Objective To explore the safety and clinic therapeutic effects of using tumor activated dendritic cells (DC) accompanied cytokine induced killer (CIK) in order to feinforce opposing anti-tumor function and to eliminate minimal residual
Autor:
Ayumu Kubota, Atae Utsunomiya, Masahito Tokunaga, Nobuaki Nakano, Mayumi Tokunaga, Shogo Takeuchi, Takahiro Itoyama, Torahiko Makino, Yoshifusa Takatsuka
Publikováno v:
Blood. 118:4483-4483
Abstract 4483 Adult T-cell leukemia/lymphoma (ATLL) is one of human T-cell leukemia virus type 1 (HTLV-1) related diseases and is usually characterized as CD4+CD8-CD25+ peripheral T-cell lymphoma with very poor prognosis. Although many chemotherapeut
Autor:
Françoise Boyer, Joelle Guilhot, Emmanuel Gyan, Jean Christophe Ianotto, Cony Makhoul, Emmanuel Raffoux, Jean Gunecht, Jean-François Viallard, Lydia Roy, Franck E. Nicolini, Benoit de Renzis, Laurence Legros, Stéphane Giraudier
Publikováno v:
Blood. 116:1974-1974
Abstract 1974 Background: Conventional therapeutic guidelines in essential thrombocytemia (ET) are based on established criteria of higher incidence of vascular complications: age more than 60 years, history of thrombosis, platelets more than 1000–
Autor:
Renato Talamini, Emanuela Vaccher, Alessandro Re, Umberto Tirelli, Michele Spina, Salvatrice Mancuso, Clara Schiantarelli, Jean Gabarre
Publikováno v:
Publons
Abstract 4827 Background: The introduction of HAART has significantly improved the outcome of pts with HD-HIV. However there are no data on the long term follow-up of HD-HIV pts treated with conventional chemotherapy (CT) regimens. In 2002, we report
Autor:
Maria N. Dimopoulou, Maria K. Angelopoulou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Xanthi Yiakoumis, Penelope Korkolopoulou, Christina Kalpadakis, Flora N. Kontopidou, Marina P. Siakantaris, Styliani I. Kokoris, Helen A. Papadaki, Gerassimos A. Pangalis, Maria Moschogiannis, Evangelia M. Dimitriadou, Marie-Christine Kyrtsonis
Publikováno v:
Blood. 118:2712-2712
Abstract 2712 Treatment of splenic marginal zone lymphomas (SMZL) is traditionally based on splenectomy. However, preliminary data suggest that rituximab monotherapy is highly effective in SMZL patients. The aim was to assess the efficacy of rituxima
Publikováno v:
Blood. 104:825-825
Conventional allogeneic HSC transplantation is limited by lack of rapidly available, HLA-matched donors & excess transplant-related mortality (TRM) in high-risk adults. Therefore, we investigated the combined use of unrelated donor UCB, utilizing 2 u